Danaparoid—Consensus Recommendations on Its Clinical Use

Danaparoid—Consensus Recommendations on Its Clinical Use

(1) Background: Danaparoid sodium is a heparinoid antithrombotic that has been used for over 40 years for prophylaxis of DVT in non-HIT patients and for the treatment of heparin-induced thrombocytopenia (HIT) with and without thrombosis. This update summarises current information on its pharmacology...

Full description

Saved in:
Bibliographic Details
Main Authors: Rupert M. Bauersachs, Edelgard Lindhoff-Last, Robert Klamroth, Andreas Koster, Marc Schindewolf, Harry Magnani
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Pharmaceuticals
Subjects:
Orgaran
danaparoid
heparinoid
anticoagulant
dosing
monitoring
Online Access:https://www.mdpi.com/1424-8247/17/12/1584
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items